199 related articles for article (PubMed ID: 26381186)
1. New TLR7 agonists with improved humoral and cellular immune responses.
Upchurch KC; Boquín JR; Yin W; Xue Y; Joo H; Kane RR; Oh S
Immunol Lett; 2015 Nov; 168(1):89-97. PubMed ID: 26381186
[TBL] [Abstract][Full Text] [Related]
2. Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075.
Spranger S; Javorovic M; Bürdek M; Wilde S; Mosetter B; Tippmer S; Bigalke I; Geiger C; Schendel DJ; Frankenberger B
J Immunol; 2010 Jul; 185(1):738-47. PubMed ID: 20511554
[TBL] [Abstract][Full Text] [Related]
3. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
[TBL] [Abstract][Full Text] [Related]
4. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
5. Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant.
Bielinska AU; Makidon PE; Janczak KW; Blanco LP; Swanson B; Smith DM; Pham T; Szabo Z; Kukowska-Latallo JF; Baker JR
J Immunol; 2014 Mar; 192(6):2722-33. PubMed ID: 24532579
[TBL] [Abstract][Full Text] [Related]
6. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
[TBL] [Abstract][Full Text] [Related]
7. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake.
Liang F; Lindgren G; Sandgren KJ; Thompson EA; Francica JR; Seubert A; De Gregorio E; Barnett S; O'Hagan DT; Sullivan NJ; Koup RA; Seder RA; Loré K
Sci Transl Med; 2017 Jun; 9(393):. PubMed ID: 28592561
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates.
Ketloy C; Engering A; Srichairatanakul U; Limsalakpetch A; Yongvanitchit K; Pichyangkul S; Ruxrungtham K
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):18-30. PubMed ID: 18571243
[TBL] [Abstract][Full Text] [Related]
9. Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.
Klauber TCB; Laursen JM; Zucker D; Brix S; Jensen SS; Andresen TL
Acta Biomater; 2017 Apr; 53():367-377. PubMed ID: 28153581
[TBL] [Abstract][Full Text] [Related]
10. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells.
Levy O; Suter EE; Miller RL; Wessels MR
Blood; 2006 Aug; 108(4):1284-90. PubMed ID: 16638933
[TBL] [Abstract][Full Text] [Related]
11. Activation of plasmacytoid dendritic cells and B cells with two structurally different Toll-like receptor 7 agonists.
Berggren O; Pucholt P; Amcoff C; Rönnblom L; Eloranta ML
Scand J Immunol; 2020 Jun; 91(6):e12880. PubMed ID: 32219875
[TBL] [Abstract][Full Text] [Related]
12. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
[TBL] [Abstract][Full Text] [Related]
13. Src Family Kinases Regulate Interferon Regulatory Factor 1 K63 Ubiquitination following Activation by TLR7/8 Vaccine Adjuvant in Human Monocytes and B Cells.
Tulli L; Cattaneo F; Vinot J; Baldari CT; D'Oro U
Front Immunol; 2018; 9():330. PubMed ID: 29545793
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and immunostimulatory activity of substituted TLR7 agonists.
Akinbobuyi B; Wang L; Upchurch KC; Byrd MR; Chang CA; Quintana JM; Petersen RE; Seifert ZJ; Boquin JR; Oh S; Kane RR
Bioorg Med Chem Lett; 2016 Sep; 26(17):4246-9. PubMed ID: 27476423
[TBL] [Abstract][Full Text] [Related]
15. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
[TBL] [Abstract][Full Text] [Related]
16. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
[TBL] [Abstract][Full Text] [Related]
17. Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release.
Filì L; Ferri S; Guarna F; Sampognaro S; Manuelli C; Liotta F; Cosmi L; Matucci A; Vultaggio A; Annunziato F; Maggi E; Guarna A; Romagnani S; Parronchi P
J Allergy Clin Immunol; 2006 Aug; 118(2):511-7. PubMed ID: 16890779
[TBL] [Abstract][Full Text] [Related]
18. R848/TLR7-Mediated Stronger CD8+ T Immunity Is Dependent on DC-NK Cell Interactions.
Zhou J; Nouri-Shirazi M; Tang H; Shen Y; Zeng M
Int Arch Allergy Immunol; 2022; 183(8):860-875. PubMed ID: 35263757
[TBL] [Abstract][Full Text] [Related]
19. A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner.
Auderset F; Belnoue E; Mastelic-Gavillet B; Lambert PH; Siegrist CA
Front Immunol; 2020; 11():580974. PubMed ID: 33262759
[TBL] [Abstract][Full Text] [Related]
20. Rabies virus lipopeptide conjugated to a TLR7 agonist improves the magnitude and quality of the Th1-biased humoral immune response in mice.
Liu R; Wang J; Yang Y; Khan I; Zhu N
Virology; 2016 Oct; 497():102-110. PubMed ID: 27449478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
